|
|
|
|
Trastuzumab (herceptin) in the medical treatment of breast [Trastuzumab (herceptine) dans le traitement medical des cancers du sein]
|
|
|
|
|
|
|
|
نویسنده
|
bayoudh l. ,afrit m. ,daldoul o. ,zarrad m. ,boussen h.
|
|
منبع
|
tunisie médicale - 2012 - دوره : 90 - شماره : 1 - صفحه:6 -12
|
|
چکیده
|
Background: trastuzumab is humanized monoclonal antibody targeting her 2 neu receptor,overexpressed in 20% of breast cancers and part of the complex of epidermal growth factor receptor. aim: to review new advances in the knowledge of the practical use of trastuzumab (herceptin ®) in breast cancer. methods: review of literature using medical data bases (medline,science direct) with the following key words: breast cancer,targeted therapy,her2 neu,transtuzumab/herceptine résults: trastuzumab represent an important advance in breast cancer treatment with an improvement of median survival in metastatic setting and overall and disease-free survival in adjuvant setting in association with chemotherapy. herceptin remain well tolerated with a low and rare risk of cardiac failure. conclusion: trastuzumab is a new therapeutic tool very intersting to ameliorate prognosis of reast cancer.
|
|
کلیدواژه
|
Breast cancer; HER2neu; Targeted therapy
|
|
آدرس
|
service de carcinologie médicale,l'institut salah azaiz,service de carcinologie médicale de l'hôpital abderrahman mami, Tunisia, service de carcinologie médicale,l'institut salah azaiz,service de carcinologie médicale de l'hôpital abderrahman mami, Tunisia, tunis faculté de médecine, Tunisia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|